This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08278/identifier/pdb/
n4http://bio2rdf.org/drugbank:
n12http://linked.opendata.cz/resource/drugbank/drug/DB08278/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08278/identifier/pubchem-substance/
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n14http://linked.opendata.cz/resource/drugbank/drug/DB08278/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB08278/identifier/chemspider/

Statements

Subject Item
n2:DB08278
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB08278 n7:DB08278
dcterms:title
1-(2-CYCLOPROPYLETHYL)-3-(1,1-DIOXIDO-2H-1,2,4-BENZOTHIADIAZIN-3-YL)-6-FLUORO-4-HYDROXYQUINOLIN-2(1H)-ONE
adms:identifier
n10:99444749 n11:NN2 n12:5273394 n13:20114428 n14:DB08278
n5:IUPAC-Name
n6:271B4896-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B489C-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B489B-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4898-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4899-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B489A-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4894-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4892-363D-11E5-9242-09173F13E4C5 n6:271B4895-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4893-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B48A2-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B48A3-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B489D-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B489E-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B48A0-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B489F-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B48A1-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B48A8-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B48AA-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B48AB-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B48A7-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B48A6-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B48A9-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4897-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B48A4-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B48A5-363D-11E5-9242-09173F13E4C5